Brokerages Set Altimmune, Inc. (NASDAQ:ALT) PT at $20.83
Shares of Altimmune, Inc. (NASDAQ:ALT – Get Free Report) have received an average recommendation of “Moderate Buy” from the nine brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the […]
Shares of Altimmune, Inc. (NASDAQ:ALT – Get Free Report) have received an average recommendation of “Moderate Buy” from the nine brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the […]
